Market Cap 54.42M
Revenue (ttm) 60,000.00
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18,566.67%
Debt to Equity Ratio 0.00
Volume 6,700
Avg Vol 23,174
Day's Range N/A - N/A
Shares Out 9.97M
Stochastic %K 57%
Beta 0.67
Analysts Strong Sell
Price Target $13.00

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which...

Industry: Biotechnology
Sector: Healthcare
Phone: 256 327 9630
Address:
601 Genome Way, Suite 2001, Huntsville, United States
d_risk
d_risk Aug. 12 at 12:36 AM
$SER - Serina Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors SER flags risks of stock price drops from large share sales and warns of unpredictable, lengthy FDA approval processes that could delay or derail product development. #Biotechnology #RegulatoryUncertainty #ProductDevelopment #StockPriceRisk #FDAApproval 🟢 Added 🟠 Removed https://d-risk.ai/SER/10-Q/2025-08-11
0 · Reply
jheerdink
jheerdink Jul. 29 at 12:44 PM
$SER - "Novel once-weekly injectable VMAT2 inhibitor targets underserved patients with serious adherence and access challenges – - Potential expansion into Huntington’s chorea – an underserved indication with high need for long-acting VMAT2 therapy" - https://finance.yahoo.com/news/serina-therapeutics-advances-poz-vmat2i-104400195.html
0 · Reply
Majid74
Majid74 Jul. 29 at 10:59 AM
0 · Reply
topstockalerts
topstockalerts Jul. 29 at 10:58 AM
Pre Market Top Gainers PT2 $SER $WGS $SGD $JFU $GTLS
0 · Reply
jheerdink
jheerdink Jul. 28 at 1:13 PM
$SER Serina Therapeutics a clinical-stage biotech co. developing its proprietary POZ Platform™ drug optimization tech announced that Steve Ledger, Ceo will participate in a fireside chat at BTIG Virtual Biotechnology Conference, on Tues July 29 at 2pm ET https://finance.yahoo.com/news/serina-therapeutics-present-btig-virtual-100000037.html
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 28 at 11:54 AM
$SER Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference By Serina Therapeutics, Inc. | July 28, 2025, 6:00 AM
0 · Reply
topstockalerts
topstockalerts Jul. 28 at 11:00 AM
Pre Market Top Gainers PT2 $GTI $MJID $SER $XXII $WETO
0 · Reply
TradingSecretsYT
TradingSecretsYT Jul. 28 at 12:50 AM
$SER In this video we look at Serina Therapeutics whcih according to analysts has a potential 140% Upside, a strong but rating and a $3.3b market opportunity plus a huge number of catalysts. https://youtu.be/ZY2aTZeXm4o
0 · Reply
ChartChartist
ChartChartist Jul. 27 at 10:16 PM
$SER on promo
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 15 at 10:59 AM
$SER pm gapper
0 · Reply
Latest News on SER
Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 29, 2025, 6:00 AM EDT - 3 months ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day


Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 15, 2025, 4:05 PM EST - 7 months ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary


AgeX Therapeutics Reports Second Quarter 2023 Financial Results

Aug 14, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports Second Quarter 2023 Financial Results


AgeX Therapeutics Reports First Quarter 2023 Financial Results

May 12, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports First Quarter 2023 Financial Results


AgeX Therapeutics Receives Stock Exchange Deficiency Letter

Apr 26, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Receives Stock Exchange Deficiency Letter


AgeX Therapeutics Reports Third Quarter 2022 Financial Results

Nov 10, 2022, 4:05 PM EST - 2 years ago

AgeX Therapeutics Reports Third Quarter 2022 Financial Results


d_risk
d_risk Aug. 12 at 12:36 AM
$SER - Serina Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors SER flags risks of stock price drops from large share sales and warns of unpredictable, lengthy FDA approval processes that could delay or derail product development. #Biotechnology #RegulatoryUncertainty #ProductDevelopment #StockPriceRisk #FDAApproval 🟢 Added 🟠 Removed https://d-risk.ai/SER/10-Q/2025-08-11
0 · Reply
jheerdink
jheerdink Jul. 29 at 12:44 PM
$SER - "Novel once-weekly injectable VMAT2 inhibitor targets underserved patients with serious adherence and access challenges – - Potential expansion into Huntington’s chorea – an underserved indication with high need for long-acting VMAT2 therapy" - https://finance.yahoo.com/news/serina-therapeutics-advances-poz-vmat2i-104400195.html
0 · Reply
Majid74
Majid74 Jul. 29 at 10:59 AM
0 · Reply
topstockalerts
topstockalerts Jul. 29 at 10:58 AM
Pre Market Top Gainers PT2 $SER $WGS $SGD $JFU $GTLS
0 · Reply
jheerdink
jheerdink Jul. 28 at 1:13 PM
$SER Serina Therapeutics a clinical-stage biotech co. developing its proprietary POZ Platform™ drug optimization tech announced that Steve Ledger, Ceo will participate in a fireside chat at BTIG Virtual Biotechnology Conference, on Tues July 29 at 2pm ET https://finance.yahoo.com/news/serina-therapeutics-present-btig-virtual-100000037.html
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 28 at 11:54 AM
$SER Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference By Serina Therapeutics, Inc. | July 28, 2025, 6:00 AM
0 · Reply
topstockalerts
topstockalerts Jul. 28 at 11:00 AM
Pre Market Top Gainers PT2 $GTI $MJID $SER $XXII $WETO
0 · Reply
TradingSecretsYT
TradingSecretsYT Jul. 28 at 12:50 AM
$SER In this video we look at Serina Therapeutics whcih according to analysts has a potential 140% Upside, a strong but rating and a $3.3b market opportunity plus a huge number of catalysts. https://youtu.be/ZY2aTZeXm4o
0 · Reply
ChartChartist
ChartChartist Jul. 27 at 10:16 PM
$SER on promo
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 15 at 10:59 AM
$SER pm gapper
0 · Reply
KhalidsCapital
KhalidsCapital Jul. 15 at 8:13 AM
Super squeeze in the making?!? Ticker AQMS AQMS is quietly holding the keys to battery sustainability. EVs are booming, but recycling is the missing piece and has the solution in hand. Government grants, patent protection, and low-float potential make this a dark horse winner. This isn’t just a clean-tech story it’s a future supply chain necessity. $BLMZ $COOT $SER $BMNR …
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jul. 15 at 4:34 AM
🌅🌅 watchlist ✅️ $GRO mid 2.50 support, if above 3, have potential to 3.40/.50, signing 200 M deal with Fictor Energia ✅️ $XAGE low 4 support, if above 4.50, have potential to 4.80/5, announces merger news with True Health ✅️ $BLMZ low .20 support, if above .25, have potential to. 35/.40 ✅️ $SER low 6 support, if above 7, have potential to 7.50/80 ✅️ $IBG low 1 support, if above 1.50, have potential to 1.75/.80 ✅️ VBIX low 6 support, if above 6.50, have potential to 6.80/.90 ✅️ OPEN low 1 support, if above 1.20, have potential to 1.40/1.50 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if current support 🚫🚫 Avoid chasing long into strength near resistance 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
tariq7863a
tariq7863a Jul. 14 at 11:17 PM
$SER 6.50 or less tomorrow. don't be bag holders
0 · Reply
tariq7863a
tariq7863a Jul. 14 at 10:56 PM
$SER tomorrow 6.00 don't be bag holders
0 · Reply
stockanalysis_
stockanalysis_ Jul. 14 at 9:39 PM
After Hours Gainers: $GRO $SER $XAGE $MOVE $BHAT View the entire list here: https://stockanalysis.com/markets/afterhours/gainers/?ref=saveontrading
0 · Reply
littleimagination
littleimagination Jul. 14 at 4:09 PM
$SER Still long SER. Weird type of pricing, it always stays sideways in this $5 to $6. dollar range. Due to the low float and insider buying. When they want to move this stock, it will skip dollars at a time. SER will be fun to ride north of $100!
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 11:00 AM
HC Wainwright & Co. has updated their rating for Serina Therapeutics ( $SER ) to Buy with a price target of 15.
0 · Reply
littleimagination
littleimagination Jun. 18 at 3:31 PM
$SER Still long SER and Wff, a newer low float Chinese ipo.
0 · Reply
jheerdink
jheerdink Jun. 10 at 6:34 PM
$SER $PFE https://finance.yahoo.com/news/registration-now-open-tribe-public-200500498.html
0 · Reply
jheerdink
jheerdink Jun. 9 at 8:20 PM
$SER Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" Featuring Serina Therapeutics’ CEO - Wednesday, June 11, 2025 -Entering year 5 of a biotech bear market, approximately 25% of the 700 – 800 publicly traded US biotech companies have negative enterprise values -Recognize the patterns that can lead to strong investment returns Meet with Serina’s CEO Steven A. Ledger Register at Smartest-Bet.TribePublic.com https://investors.serinatherapeutics.com/news/news-details/2025/Registration-Is-Now-Open-For-Tribe-Publics-CEO-Presentation-and-QA-Webinar-Event-Is-the-Beaten-Down-Biotech-Sector-the-Smartest-Bet-in-Todays-Volatile-Market/default.aspx
0 · Reply
jheerdink
jheerdink Jun. 4 at 6:22 PM
$SER Serina Therapeutics Strategically Adds Karuna Therapeutics’ CMO Dr. Stephen Brannan: A Power Move for CNS Innovation & Beyond ( $TAK $LLY ) https://vistapglobal.com/serina-therapeutics-strategically-adds-karuna-therapeutics-cmo-dr-stephen-brannan-a-power-move-for-cns-innovation-beyond-ser-bmy-tak-nvs-lly/ #
0 · Reply
littleimagination
littleimagination May. 16 at 12:44 PM
$SER Hold on tight to SER. Don't let them steal your shares for under $150.
0 · Reply